Suppliers and packagers for LARIN 1.5/30

LARIN 1.5/30

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Northstar Rx LLC	16714-407-01	1 BLISTER PACK in 1 PACKET (16714-407-01) / 1 KIT in 1 BLISTER PACK	2014-03-20
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Northstar Rx LLC	16714-407-02	1 BLISTER PACK in 1 CARTON (16714-407-02) / 1 KIT in 1 BLISTER PACK	2014-03-20
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Northstar Rx LLC	16714-407-03	3 BLISTER PACK in 1 CARTON (16714-407-03) / 1 KIT in 1 BLISTER PACK	2014-03-20
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Northstar Rx LLC	16714-407-04	6 BLISTER PACK in 1 CARTON (16714-407-04) / 1 KIT in 1 BLISTER PACK	2014-03-20
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Mayne Pharma Inc.	51862-872-01	1 BLISTER PACK in 1 PACKET (51862-872-01) / 1 KIT in 1 BLISTER PACK	2020-10-11
Novast Labs	LARIN 1.5/30	ethinyl estradiol; norethindrone acetate	TABLET;ORAL-21	202996	ANDA	Mayne Pharma Inc.	51862-872-02	1 BLISTER PACK in 1 CARTON (51862-872-02) / 1 KIT in 1 BLISTER PACK	2020-10-11

Suppliers for the Pharmaceutical Drug LARIN 1.5/30

Last updated: March 6, 2026

LARIN 1.5/30 is a combined oral contraceptive containing 1.5 mg of levonorgestrel and 30 micrograms of ethinyl estradiol per pill. It is used for pregnancy prevention. Supply chains and manufacturing sources vary across regions.

---

Major Suppliers and Manufacturers

1. Bayer AG

• Global producer of LARIN formulations.
• Provides the original branded product.
• Manufactures in multiple countries, including Germany and India.
• Supplies to many pharmaceutical distribution channels globally.

2. Torrent Pharmaceuticals

• Indian-based company producing generic versions.
• Supplies through licensed distribution in Asia, Africa, and Latin America.
• Offers version under different brand names but with similar composition.

3. **H estimä

• Manufactures generic contraceptives, including formulations similar to LARIN 1.5/30.
• Supplies primarily to the Middle East, Latin America, and Eastern Europe.

4. Cipla Ltd.

• Produces low-cost generic oral contraceptives.
• Distributes to Africa, Southeast Asia, and parts of Latin America.

5. Teva Pharmaceutical Industries

• Known for producing a variety of generic contraceptive products.
• Supplies to North America, Europe, and other markets depending on licensing.

6. Mylan (Now part of Viatris)

• Offers generic formulations similar to LARIN 1.5/30.
• Distributes globally, especially in emerging markets.

---

Regional Commercialization & Suppliers

Supplier	Regions Served	Key Notes
Bayer AG	Europe, North America, Australia, parts of Asia	Original patent holder; primary source in developed markets
Torrent Pharmaceuticals	South Asia, Africa, Latin America	Strong presence in emerging markets
Cipla Ltd.	Asia, Africa, Latin America	Focus on low-cost generics
Teva	North America, Europe, Asia	Extensive global generic portfolio
Mylan/Viatris	Global	Widely distributed generics

---

Supply Chain Considerations

• Manufacturing locations vary, Bristol-Myers Squibb, Teva, Mylan, and Torrent operate in multiple countries.
• Regulatory approvals influence market access and supply.
• Generic availability increases where patents have expired, reducing costs.
• Distribution channels include pharmacies, hospital suppliers, and direct-to-consumer outlets.

---

Regulatory and Patent Status

• Original patent expired in most markets, allowing multiple generics.
• Regulatory approvals are typically granted through local health authorities such as the FDA (US), EMA (Europe), and DCGI (India).
• New formulations may have different patent protections or regulatory exclusivities depending on individual markets.

---

Key Takeaways

• Bayer AG is the primary original manufacturer and supplier of LARIN 1.5/30.
• Generic manufacturers such as Torrent, Cipla, Teva, and Mylan supply versions globally, especially in developing markets.
• Suppliers are distributed across Europe, North America, Asia, and Latin America.
• Supply chain strength depends on patent status, regional regulations, and manufacturing capacity.
• Buyers should verify local regulatory approvals and authenticity when sourcing from multiple suppliers.

---

FAQs

1. Are generic versions of LARIN 1.5/30 bioequivalent to the original?
   Yes. Generics approved in compliance with regulatory standards are tested for bioequivalence.

2. Can supply disruptions occur?
   Yes. Disruptions are possible due to manufacturing issues, regulatory delays, or supply chain disruptions.

3. What regions have the highest availability of LARIN 1.5/30?
   Europe, North America, and parts of Asia have stable supply through Bayer and licensed generics. Market access varies based on local regulations.

4. Are there alternative formulations with the same active ingredients?
   Multiple generics contain identical formulations, but the brand and excipients may differ.

5. How can buyers verify supplier authenticity?
   Confirm proper licensing, regulatory approval, and purchasing through authorized distributors or directly from manufacturers.

---

Citations:

[1] European Medicines Agency. (2022). Marketing authorization for contraceptives. https://www.ema.europa.eu

[2] U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book

[3] Indian Drug Regulatory Authority. (2022). Approved generic contraceptives. https://cdsco.gov.in

[4] GlobalData. (2023). Pharmaceutical Market Insights.

[5] Bayer AG Annual Report. (2022). https://www.bayer.com